IP Library Granted Patent US 12,226,250
Granted Patent B2
US 12,226,250 · App. 16/498,631 · Granted Feb 18, 2025

Multiple modality body composition analysis

Inventors: Kevin E. Wilson (Marlborough, MA); John A. Shepherd (Oakland, CA); Bennett K. Ng (Oakland, CA); Mark Guetersloh (Marlborough, CA); Chao Huang (Marlborough, MA); Thomas L. Kelly (Marlborough, MA); Wei Wang (Marlborough, MA); Howard Weiss (Marlborough, MA)
Assignees: Hologic, Inc.; The Regents of the University of California
A61B6/5247A61B5/0064A61B5/0077A61B5/1075A61B5/1079A61B5/4872A61B5/4875A61B6/0407A61B6/4452A61B6/482A61B6/505G01G19/445
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,250
App. No.
16/498,631
Granted
Feb 18, 2025
Kind
B2
Abstract

Systems and methods for determining body composition by combining dual-energy x-ray (DXA) technology with three-dimensional (3D) optical technology and/or bioimpedance technology. A multi-modality scanning system may include a dual-energy x-ray source and an x-ray detector mounted to opposing sides a c-arm and configured to scan a patient on a optically translucent table. The system may also include one or more 3D optical imaging devices to capture 3D optical images of the patient substantially concurrently with the emission of the dual energy x-rays. A bioimpedance machine may also be included in the multi-modality scanning system. Data based on the dual-energy x-rays may be combined with the data from the 3D optical images and/or the bioimpedance data to generate values of at least three compartments selected from: bone, fat tissue, lean tissue, dehydrated lean tissue, and water.

Claims (45)

1. A system comprising:

a support structure configured to move along an axis of a scanning target;

a dual-energy x-ray source mounted to the support structure, the dual energy x-ray source configured to emit dual-energy x-rays towards the scanning target along a scan path;

an x-ray detector configured to detect the dual-energy x-rays emitted from the dual-energy x-ray source after passing through the scanning target;

a first 3D optical imaging device mounted to the support structure and configured to obtain a first 3D optical image of a first side of the scanning target along the scan path; and

a second 3D optical imaging device mounted to the support structure and configured to concurrently obtain a second 3D optical image of a second side of the scanning target, the second side being opposite the first side with respect to the scanning target; and

a processing device communicatively coupled to the x-ray detector and the first 3D optical imaging device;

wherein at least the first 3D optical imaging device and the second 3D optical imaging device are fixed in place with respect to the scanning target to capture surfaces of the scanning target to form a 3D model of the scanning target; and

the processing device is configured to determine, on a per-pixel basis, amounts of at least three of: bone, fat tissue, lean tissue, dehydrated lean tissue, and water.

2. The system of claim 1 , further comprising an optically translucent patient support table or wall on which the scanning target is positioned, wherein the optically translucent table is disposed between the dual energy x-ray source and the detector.

3. The system of claim 1 , further comprising a scale to measure the weight of the scanning target.

4. The system of claim 3 , wherein the x-ray source is configured to move along the support structure in a direction transverse to the longitudinal axis of the scanning target.

5. The system of claim 1 , wherein:

the support structure has a first arm and a second arm, the first arm and the second arm disposed on opposite sides of a scanning target; and

the first 3D optical imaging device is mounted to the first arm.

6. The system of claim 1 , wherein the first 3D optical imaging device is selected from a group consisting of a stereoscopic device, a laser scanning device, a structured light device, and a modulated light device.

7. The system of claim 1 , wherein the processing device is configured to compute a thickness of the scanning target on a per pixel basis.

8. The system of claim 1 , further comprising a bioimpedance analysis device mounted to a portion of the system and communicatively coupled to the processing device.

9. The system of claim 1 , wherein the system is configured to scan a patient in a standing position.

10. A system comprising:

a dual-energy x-ray source configured to move vertically along a longitudinal axis of the scanning target, the dual energy x-ray source configured to emit dual-energy x-rays towards a first side of the scanning target;

an x-ray detector configured to move in a vertical scan path along the longitudinal axis of the scanning target and configured to detect the dual-energy x-rays emitted from the dual-energy x-ray source after passing through the scanning target;

a first 3D optical imaging device configured to obtain a first 3D optical image of the first side of the scanning target along the vertical scan path;

a second 3D optical imaging device configured to concurrently obtain a second 3D optical image of a second side of the scanning target along the vertical scan path, the second side being opposite the first side with respect to the scanning target; and

a processing device communicatively coupled to the x-ray detector and the first 3D optical imaging device;

wherein at least the first 3D optical imaging device and the second 3D optical imaging device are fixed in place with respect to the scanning target to capture surfaces of the scanning target to form a 3D model of the scanning target; and

the processing device is configured to determine, on a per-pixel basis, amounts of at least three of: bone, fat tissue, lean tissue, dehydrated lean tissue, and water.

11. The system of claim 10 , further comprising a radiolucent, transparent wall disposed between the dual-energy x-ray source and the x-ray detector.

12. The system of claim 1 , wherein the first 3D optical imaging device is configured to capture the 3D optical image within one second before or after the dual-energy x-rays are emitted towards the scanning target.

13. The system of claim 10 , wherein the first 3D optical imaging device is configured to capture the optical image within one second before or after the dual-energy x-rays are emitted towards the scanning target.

14. The system of claim 1 , wherein the first 3D optical imaging device is configured to capture a position and shape of a patient at the same time as information from the dual-energy x-rays is obtained.

15. The system of claim 10 , wherein at least one of the first 3D optical imaging device and the second 3D optical imaging device is configured to capture a position and shape of a patient at the same time as information from the dual-energy x-rays is obtained.

16. A system comprising:

a support structure configured to move along an axis of a scanning target;

a dual-energy x-ray source mounted to the support structure, the dual energy x-ray source configured to emit dual-energy x-rays towards the scanning target along a scan path;

an x-ray detector configured to detect the dual-energy x-rays emitted from the dual-energy x-ray source after passing through the scanning target; and

at least one optical imaging device mounted to the support structure and configured to obtain an optical image of a first side of the scanning target along the scan path;

a bioimpedance analysis device mounted to a portion of the system and communicatively coupled to a processing device, wherein a position of electrodes of the bioimpedance analysis device is based on at least one of dual-energy x-ray data provided by the dual-energy x-ray source and optical data provided by the at least one optical imaging device; and

the processing device being communicatively coupled to the x-ray detector and the at least one optical imaging device and being configured to determine, on a per-pixel basis, amounts of at least three of: bone, fat tissue, lean tissue, dehydrated lean tissue, and water.

17. The system of claim 1 , further comprising:

a third 3D optical imaging device mounted to the support structure and configured to obtain a third 3D optical image of the scanning target along the scan path;

wherein the third 3D optical image combined with the first 3D optical image and the second 3D optical image form the 3D model of the scanning target.

18. The system of claim 10 , further comprising:

a third 3D optical imaging device mounted to the support structure and configured to obtain a third 3D optical image of the scanning target along the scan path;

wherein the third 3D optical image combined with the first 3D optical image and the second 3D optical image form the 3D model of the scanning target.

Assignments (4)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2022
From: WILSON, KEVIN E.; GUETERSLOH, MARK; HUANG, CHAO; KELLY, THOMAS L.; WANG, WEI; WEISS, HOWARD
To: HOLOGIC, INC.
Reel/Frame 061834/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2022
From: SHEPHERD, JOHN A.; NG, BENNETT K.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 061834/0215 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
Continuity (2)
Provisional Application 62480017 · Mar 31, 2017
Related Publication 20200029927A1 · Jan 30, 2020
References Cited (172)
US 4811373A · Stein · 1989 [cited by applicant]
US 4831527A · Clark · 1989 [cited by applicant]
US 4947414A · Stein et al. · 1990 [cited by applicant]
US 4980904A · Sones et al. · 1990 [cited by applicant]
US 5040199A · Stein · 1991 [cited by applicant]
US 5305368A · Bisek et al. · 1994 [cited by applicant]
US 5335260A · Arnold · 1994 [cited by applicant]
US 5771272A · Berger · 1998 [cited by examiner]
US 5778045A · von Stetten · 1998 [cited by applicant]
US 5949846A · Stein · 1999 [cited by examiner]
US 6081582A · Mazess · 2000 [cited by applicant]
US 6102567A · Cabral · 2000 [cited by applicant]
US 6160866A · Mazess · 2000 [cited by applicant]
US 6173034B1 · Chao · 2001 [cited by applicant]
US 6198797B1 · Majima et al. · 2001 [cited by applicant]
US 6215846B1 · Mazess · 2001 [cited by applicant]
US 6233473B1 · Shepherd · 2001 [cited by applicant]
US 6315447B1 · Nord · 2001 [cited by applicant]
US 6468209B1 · Heymsfield · 2002 [cited by applicant]
US 6816564B2 · Charles, Jr. · 2004 [cited by applicant]
US 6969350B1 · Hawthorne · 2005 [cited by applicant]
US 6999549B2 · Sabol et al. · 2006 [cited by applicant]
US 7198404B2 · Navab · 2007 [cited by examiner]
US 7444961B1 · Ellis · 2008 [cited by applicant]
US 7595043B2 · Hedrick · 2009 [cited by applicant]
US 7725153B2 · Kelly et al. · 2010 [cited by applicant]
US 7801350B2 · L Bras et al. · 2010 [cited by applicant]
US 8300911B1 · Payne et al. · 2012 [cited by applicant]
US 8483458B2 · Payne et al. · 2013 [cited by applicant]
US 8634629B2 · Wilson · 2014 [cited by applicant]
US 8792689B2 · Kelly et al. · 2014 [cited by applicant]
US 9086356B1 · Kelly et al. · 2015 [cited by applicant]
US 9179873B2 · Kelly et al. · 2015 [cited by applicant]
US 9504406B2 · Chetham et al. · 2016 [cited by applicant]
US 9642585B2 · Wilson · 2017 [cited by applicant]
US 9865050B2 · Kelly et al. · 2018 [cited by applicant]
US 10390784B2 · Wilson · 2019 [cited by applicant]
US 10470705B2 · Kelly · 2019 [cited by applicant]
US 10499865B2 · Wilson et al. · 2019 [cited by applicant]
US 10515451B2 · Kelly · 2019 [cited by applicant]
US 10646159B2 · Kelly · 2020 [cited by applicant]
US 11701079B2 · Wilson · 2023 [cited by applicant]
US 20010053202A1 · Mazess · 2001 [cited by applicant]
US 20020070365A1 · Karellas · 2002 [cited by applicant]
US 20040077088A1 · Charles, Jr. et al. · 2004 [cited by applicant]
US 20040101086A1 · Sabol et al. · 2004 [cited by applicant]
US 20040247076A1 · Navab · 2004 [cited by examiner]
US 20050010106A1 · Lang et al. · 2005 [cited by applicant]
US 20050215882A1 · Chenevert · 2005 [cited by applicant]
US 20060074288A1 · Kelly et al. · 2006 [cited by applicant]
US 20070223795A1 · Qing et al. · 2007 [cited by applicant]
US 20070238957A1 · Yared · 2007 [cited by applicant]
US 20090279672A1 · Reiner · 2009 [cited by applicant]
US 20100081960A1 · McKenna · 2010 [cited by examiner]
US 20100086185A1 · Weiss · 2010 [cited by applicant]
US 20100168530A1 · Chetham · 2010 [cited by applicant]
US 20100168551A1 · Moeller · 2010 [cited by applicant]
US 20100234719A1 · Kelly et al. · 2010 [cited by applicant]
US 20110002522A1 · Goto · 2011 [cited by applicant]
US 20110058725A1 · Markwardt et al. · 2011 [cited by applicant]
US 20110158386A1 · Payne et al. · 2011 [cited by applicant]
US 20110164798A1 · Masumoto · 2011 [cited by applicant]
US 20110235886A1 · Kelly et al. · 2011 [cited by applicant]
US 20110311122A1 · Kelly · 2011 [cited by applicant]
US 20120004570A1 · Shimizu · 2012 [cited by applicant]
US 20130051523A1 · Davydov et al. · 2013 [cited by applicant]
US 20130121461A1 · Toll · 2013 [cited by applicant]
US 20130308752A1 · Wilson · 2013 [cited by applicant]
US 20140288420A1 · Goossen · 2014 [cited by examiner]
US 20140371570A1 · Davis et al. · 2014 [cited by applicant]
US 20150036910A1 · Kelly et al. · 2015 [cited by applicant]
US 20150146851A1 · Wilson · 2015 [cited by applicant]
US 20150374291A1 · Kelly et al. · 2015 [cited by applicant]
US 20160228057A1 · Kelly et al. · 2016 [cited by applicant]
US 20170046837A1 · Leinhard et al. · 2017 [cited by applicant]
US 20170135655A1 · Wang et al. · 2017 [cited by applicant]
US 20180021001A1 · Wilson · 2018 [cited by applicant]
US 20180049710A1 · Wilson · 2018 [cited by applicant]
US 20180189948A1 · Kelly · 2018 [cited by applicant]
US 20190059829A1 · Han · 2019 [cited by applicant]
US 20190102877A1 · Payne et al. · 2019 [cited by applicant]
US 20200046307A1 · Wilson · 2020 [cited by applicant]
US 20200060636A1 · Wilson · 2020 [cited by applicant]
US 20200167921A1 · Kelly · 2020 [cited by applicant]
US 20210052243A1 · Don et al. · 2021 [cited by applicant]
US 20210150704A1 · Bruening et al. · 2021 [cited by applicant]
US 20210361251A1 · Wilson · 2021 [cited by applicant]
US 20220225957A1 · Kelly · 2022 [cited by applicant]
CN 1767788 · 2006 [cited by applicant]
CN 202723867 · 2013 [cited by applicant]
DE 1020120204429 · 2013 [cited by applicant]
EP 0747008 · 1996 [cited by applicant]
EP 1882447 · 2008 [cited by applicant]
JP H04263842 · 1992 [cited by applicant]
JP H09108206 · 1997 [cited by applicant]
JP H10151127 · 1998 [cited by applicant]
JP 2004081394 · 2004 [cited by applicant]
JP 2007524438 · 2007 [cited by applicant]
JP 2010042129 · 2010 [cited by applicant]
JP 201057953 · 2010 [cited by applicant]
JP 2010510835 · 2010 [cited by applicant]
JP 2010253049 · 2010 [cited by applicant]
JP 2010253106 · 2010 [cited by applicant]
JP 2011024773 · 2011 [cited by applicant]
JP 2013516706 · 2013 [cited by applicant]
JP 6047347 · 2016 [cited by applicant]
JP 2018506385 · 2018 [cited by applicant]
KR 20180038251 · 2018 [cited by applicant]
WO 2003052398 · 2003 [cited by applicant]
WO 2010051600 · 2010 [cited by applicant]
WO 2010095709 · 2012 [cited by applicant]
WO 2014066906 · 2014 [cited by applicant]
WO 2016138262 · 2016 [cited by applicant]
WO 2016177798 · 2016 [cited by applicant]
WO WO2017055352A1 · 2017 [cited by examiner]
WO 2018192909 · 2018 [cited by applicant]
Malkov et al. ( “Combining 3D optical imaging and dual energy absorptiometry to measure three compositional components” Proc SPIE Int Soc Opt Eng., Feb. 2014) (Year: 2014). [cited by examiner]
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2018/023817 mailed Sep. 4, 2018, 15 pages. [cited by applicant]
Malkov, S. et al., “Combining 3D optical imaging and dual energy absorptiometry to measure three compositional components”, Progress in Biomedical Optics and Imaging, SPIE—International society for Optical Engineering, … [cited by applicant]
Michael et al., “Monte Carlo modelling of an extended DXA technique”, Physics in Medicine and Biology, vol. 43, No. 9, Sep. 1, 1998, pp. 2583-2596. [cited by applicant]
European Communication in Application 18716810.9, mailed Nov. 10, 2020, 9 pages. [cited by applicant]
PCT International Preliminary Report and on Patentability in International Application PCT/US2018/023817, mailed Oct. 1, 2019, 7 pages. [cited by applicant]
Yamada, Yosuke, The appraisal method of Yosuke, and the amount of skeletal muscle and muscular power, medical development, Mar. 1, 2014, vol. 248, No. 9, pp. 670-678, with an English translation summary. [cited by applicant]
Chan, “Performance of Dual-Energy X-ray Absorptiometry in Evaluating Bone, Lean Body Mass, and Fat in Pediatric Subjects”, Journal of Bone and Mineral Research, vol. 7 (Year 1992), 7 pgs. [cited by applicant]
De Lorenzo, A. et al., “Predicting body cell mass with bioimpedance by using theoretical methods: a technological review”, J. Appl. Physiol 1997; 82: 1542-58. [cited by applicant]
Lehmann et al., “Generalized Image Combinations in Dual KVP Digital Radiography”, Med. Phys. 8(5) Sep./Oct. 1981, 9 pgs. [cited by applicant]
Lustgarten, M.S. et al., “Assessment of Analytical Methods Used to Measure Changes in Body Composition in the Elderly and Recommendations for Their Use in Phase II Clinical Trials”, J. Nutr. Health Aging, 15(5): 368-375… [cited by applicant]
McKiernan F.E., et al. “A long femur scan field does not alter proximal femur bone mineral density measurements by dual-energy X-ray absorptiometry.” J Clin Densitom. Jul.-Sep. 2011;14(3):354-8. [cited by applicant]
PCT International Preliminary Report on Patentability in International Application PCT/US2016/019562, dated Aug. 29, 2017, 8 pgs. [cited by applicant]
PCT International Search Report and Written Opinion in International Application PCT/US2016/019562, mailed Jul. 21, 2016, 15 pages. [cited by applicant]
Pietrobelli, A. et al., “Dual-energy X-ray absorptiometry: fat estimation errors due to variation in soft tissue hydration”, The American Physiological Society, E808-E816 (1998). [cited by applicant]
Prado, C. et al., “Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention”, Journal of Parental and Enteral Nutrition, 38(8): 940-953 (2014). [cited by applicant]
Sayer, A.A. et al., “New horizons in the pathogenesis, diagnosis and management of sarcopenia”, Age and Ageing, 42: 145-150 (2013). [cited by applicant]
Shane, E., et al. “Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.” J Bone Miner Res. Nov. 2010;25(11):2267-94. [cited by applicant]
Shane, E., et al.“Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research.” J Bone Miner Res. May 28, 2013. doi: 10.1002/jbmr.1998. … [cited by applicant]
Sorenson, J.A. et al., “Simulation of dual-energy x-ray absorptiometry”, Medical Physics, 16(1): 75-80 (1989). [cited by applicant]
Wear, J. et al., “CZT detector for dual-energy x-ray absorptiometry (DEXA)”, Proceedings of SPIE, 4142: 175-188 (2000). [cited by applicant]
WHO publication—Kanis JA, on behalf of the World Health Organisation Scientific Group, “Assessment of osteoporosis at the primary health care level”, WHO Collaborating Centre for Metabolic Bone Diseases, University of S… [cited by applicant]
Wilson, J.P et al., “Improved 4-Compartment body-composition model for a clinically accessible measure of total body protein”, Am J Clin Nutr. 2013; 97: 497-504. [cited by applicant]
Wilson, J.P. et al., “Dual-Energy X-Ray absorpitometry-based body volume measurement for 4-compartment body composition”, The American Journal of Clinical Nutrition, 2012; 95 (1): 25-31. [cited by applicant]
Bertin et al., “Measurement of visceral adipose tissue by DXA combined with anthropometry in obese humans,” Int J Obes Relat Metab Disord., 24(3):263-270 (Mar. 2000). [cited by applicant]
Gronenmeyer et al., “Fast Adipose Tissue (FAT) Assessment by MRI,” Magnetic Resonance Imaging, 18:815-818 (2000). [cited by applicant]
Hayashi et al., “Visceral Adiposity and the Prevalence of Hypertension in Japanese Americans, ” Circulation, 108:1718-1723 (2003). [cited by applicant]
Hill et al., “Estimating Abdominal Adipose Tissue With DXA and Anthropometry,” Obesity, 15(2):504-510 (Feb. 2007). [cited by applicant]
Hologic Clarity of Vision, Discovery QDR Series Advanced Point-of-Care Bone Health Assessment, Hologic Osteoporosis Assessment (May 2004), 13 pages. [cited by applicant]
Hologic Clarity of Vision, Explorer Fan-Beam DXA for the Cost-Conscious Practice, Hologic Osteoporosis Assessment (Jan. 2004), 11 pages. [cited by applicant]
Jensen et al., “Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry,” Am J Clin Nutr., 61(2):274-278 (Feb. 1995). [cited by applicant]
Kamel et al., “Usefulness of Anthropometry and DXA in Predicting Intra-abdominal Fat in Obese Men and Women,” Obesity Research, 8(1) 36-42 (2000). [cited by applicant]
Kelly et al., “DXA Body Composition: Theory and Practice,” Appl Radia., 49(5:6):511-513 (1988). [cited by applicant]
Kobayashi et al., “A novel method of measuring intra-abdominal fat vol. using helical computed tomography,” International Journal of Obesity, 26:398-402 (2002). [cited by applicant]
Krotkiewski et al., “Impact of Obesity on Metabolism in Men and Women. Importance of Regional Adipose Tissue Distribution,” J Clin Invest., The American Society for Clinical Investigation, Inc., 72:1150-1162 (1983). [cited by applicant]
Kvist et al., “Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations 1-3,” Am J Clin Nutr, 48:1351-1361 (1988). [cited by applicant]
Ley, “Sex- and menopause-associated changes in body-fat distribution,” Am J Clin Nut, 55:950-954 (1993). [cited by applicant]
Montague et al., “Perspectives in Diabetes the Perils of Portliness Causes and Consequences of Visceral Adiposity,” Diabetes, 49:883-888 (2000). [cited by applicant]
Morricone et al., “Relationship of Visceral Fat Distribution to Angiographically Assessed Coronary Artery Disease: Results in Subjects With or Without Diabetes or Impaired Glucose Tolerance,” PMID: 12616807 [PubMed—inde… [cited by applicant]
Nicklas et al., “Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women,” Epidemiology/Health Services/Psychosocial Research, Diabetes Care, 26:1413-1420 (May 2003). [cited by applicant]
Pritchard et al., “Evaluation of Dual Energy X-Ray Absorptiometry as a Method of Measurement of Body Fat,” European Journal of Clinical Nutrition, 47:216-228 (1993). [cited by applicant]
Slosman et al., “Assessment of Whole-Body Composition With Dual-Energy X-Ray Absorptiometry,” Radiology, 185:593-598 (1992). [cited by applicant]
Trueth et al., “Estimating Intraabdominal Adipose Tissue in Women by Dual-Energy X-Ray Absorptiometry,” Am J Clin Nutr, 62:427-432 (1995). [cited by applicant]
Sanada et al., “A cross-sectional study of sarcopenia in Japanese men and women: Reference values and association with cardiovascular risk factors”, European Journal of Applied Physiology 110(1): 57-65, Sep. 2010. [cited by applicant]
Chan-Shien, Ho, et al., “Application of deep learning neural network in predicting bone mineral density from plain X-ray radiography”, Archives of Osteoporosis, Springer, London, vol. 16, No. 1, Oct. 9, 2021, 12 pages. [cited by applicant]
De Souza, Joao et al., “Predicting body measures from 2D images using Convolutional Neural Networks”, 2020 International Joint Conference on Neural Networks (IJCNN), IEEE, Jul. 19, 2020, pp. 1-6. [cited by applicant]
Miccini, Riccardo et al., “HRTF Individualization using Deep Learning”, 2020 IEEE Conference on Virtual Reality and 3D User Interfaces Abstracts and Workshops (VRW), IEEE, Mar. 22, 2020, pp. 390-395. [cited by applicant]
International Search Report for PCT/US2022/080252, dated Mar. 10, 2023 (19 pages). [cited by applicant]
Stein et al., “A Dual-Energy X-Ray Bone Densitometer incorporating an internal reference systems”, Workshop on Non-Invasive Bone Measurements, Leuven, Belgium, Sep. 1987, 26 pages. [cited by applicant]
Author Unknown, “National Health and Nutrition Examination Survey (NHANES): Dual Energy Xray Absorptiometry (DXA) Procedures Manual”, CDC, Jan. 2017, 115 pages. [cited by applicant]
Tan et al., “Sarcopenia in an Overweight or Obese Patient is an Adverse Prognostic Factor in Pancreatic Cancer”, Xlin Cancer Res 2009; 15(22), Nov. 15, 2009, pp. 6973-6979. [cited by applicant]
European Communication in Application 24193308.4, mailed Sep. 24, 2024, 8 pages. [cited by applicant]
Hayes et al., “DXA: Potential for Creating a Metabolic Map of Organ-Tissue Resting Energy Expenditure Components”, Obesity Research vol. 10, No. 10, Oct. 2002, pp. 969-977. [cited by applicant]
Ho, Chan-Shien et al., “Application of deep learning neural network in predicting bone mineral density from plain X-ray radiography”, Archives of Osteoporosis, Springer London, vol. 16, No. 1, Oct. 9, 2021, 12 pgs. [cited by applicant]
Rafael do Espirit Santo, “Principal Component Analysis applied to Digital Image Compression”, Einstein (Sao Paulo) 10 (2), Jun. 2012 (available at https://doi.ord/10.1590S1679-45082012000200004), pp. 135-139. [cited by applicant]
Zimmermann et al., “Detection of overweight and obesity in a national sample of 6-12 year old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Pre… [cited by applicant]